SGMT vs UPST · $403.2M cap vs P/E 74, rev $672.9M
Sagimet Biosciences Inc. Series A Common Stock (SGMT) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
SGMT does not have a complete income-statement cache yet.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
SGMT currently screens at market cap $403.2M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the SGMT and UPST stock pages for the full models.
Not investment advice.